SLC9A3 Knockout HCT 116 Cell Line
Cat.No.:
EDC08385
Species:
Human
Cell Name:
HCT 116
Gene:
SLC9A3
Gene ID:
6550
Size:
1×10⁶cells
SLC9A3 Knockout Cell Line (HCT116) is an exclusive upgraded CRISPR/Cas9 system-mediated gene knockout cell, with the advantages of Optimized Strategy Design, Efficient Cell Transfection, High-Performance Cas9 Protein and Hassle-Free Cell Selection.
| Cat.No. | EDC08385 |
|---|---|
| Product Name | SLC9A3 Knockout HCT 116 Cell Line |
| Cell Line | HCT 116 |
| Cellosaurus ID | CVCL_0291 |
| Cell Line Synonyms | HCT-116, HCT.116, HCT_116, HCT116, HCT116wt, HCT-116/P, HCT-116/parental, CoCL2 |
| Gene | SLC9A3 |
| NCBI Gene ID | |
| Gene Synonyms | DIAR8|NHE-3|NHE3 |
| Summary |
The protein encoded by this gene is an epithelial brush border Na/H exchanger that uses an inward sodium ion gradient to expel acids from the cell. Defects in this gene are a cause of congenital secretory sodium diarrhea. Pseudogenes of this gene exist on chromosomes 10 and 22. [provided by RefSeq, Mar 2016]
|
| Associated Diseases | Colorectal Carcinoma |
| QC | Indels validated by Sanger sequencing; sterility confirmed via microbial testing. |
* For research use only. Not intended for use in humans or animals, including clinical, therapeutic, or diagnostic purposes.
| Loci | STR Info (Sample Cell) Sample Cell Line: HCT 116 | STR Info (Cell bank) Cell Line: HCT 116 | ||||||
| Allele1 | Allele2 | Allele3 | Allele4 | Allele1 | Allele2 | Allele3 | Allele4 | |
| Amelogenin | X | X | ||||||
| CSF1PO | 7 | 10 | 7 | 9 | 10 | 11 | ||
| D2S1338 | 16 | 16 | ||||||
| D3S1358 | 12 | 17 | 18 | 19 | 12 | 18 | 19 | |
| D5S818 | 10 | 11 | 10 | 11 | ||||
| D7S820 | 11 | 12 | 11 | 12 | ||||
| D8S1179 | 10 | 12 | 14 | 15 | 10 | 12 | 14 | 15 |
| D13S317 | 10 | 12 | 10 | 12 | ||||
| D16S539 | 11 | 13 | 11 | 12 | 13 | 14 | ||
| D18S51 | 16 | 17 | 16 | 17 | ||||
| D19S433 | 12 | 13 | 12 | |||||
| D21S11 | 29 | 30 | 29 | 30 | ||||
| FGA | 18 | 23 | 18 | 23 | ||||
| Penta D | 9 | 13 | 9 | 13 | ||||
| Penta E | 12 | 13 | 14 | 12 | 13 | 14 | ||
| TH01 | 8 | 9 | 8 | 9 | ||||
| TPOX | 8 | 8 | ||||||
| vWA | 17 | 21 | 22 | 23 | 17 | 21 | 22 | 23 |
| D6S1043 | 13 | |||||||
| D12S391 | 17 | 21 | 22 | |||||
| D2S441 | 11 | 12 | ||||||
* STR authentication data of this cell line matches with that of cell lines sourced from ATCC, DSMZ, JCRB, and RIKEN databases.
Conclusion: The STR identification of this cell is correct.
Conclusion: The STR identification of this cell is correct.
FAQ
Which is better for studying SLC9A3 function, SLC9A3 Knockout HCT 116 Cell Line or SLC9A3 overexpression HCT 116 Cell Line?
The choice depends on whether you are studying SLC9A3 (NHE3)'s role in sodium-hydrogen exchange and intestinal/renal salt and water absorption, or its emerging functions in inflammatory bowel disease and tenapanor pharmacology. The Knockout line is the standard tool for asking whether NHE3 is required for these processes — NHE3 is the principal apical Na+/H+ exchanger in intestinal epithelium and renal proximal tubule. Overexpression is useful for studying NHE3 regulation by trafficking and post-translational modifications.
For intestinal transport research, the EDITGENE SLC9A3 Knockout in HCT 116 is relevant — HCT 116, while a cancer line, retains some intestinal epithelial features and supports NHE3 functional studies. The line is particularly valuable as a genetic specificity control for tenapanor (NHE3 inhibitor approved for IBS-C and CKD-associated hyperphosphatemia). Rescue with wild-type or trafficking-deficient NHE3 enables regulatory mechanism studies.
What are the application scenarios for this model?
Primary applications:
• Na+/H+ exchange activity: BCECF-based intracellular pH measurement following ammonium chloride pulse or hypertonic challenge to quantify NHE3-dependent pH recovery.
• Tenapanor specificity: critical genetic control for tenapanor (NHE3 inhibitor) on-target activity testing in intestinal epithelial contexts.
• NHE3 trafficking studies: surface biotinylation and imaging-based analysis of NHE3 regulation by NHERF proteins and trafficking machinery.
• Sodium absorption studies: short-circuit current or transepithelial sodium absorption measurements where applicable.
EDITGENE recommends this model for researchers investigating Na+/H+ exchanger biology, intestinal salt and water absorption, and NHE3-targeted therapeutic development.
Is this SLC9A3 Knockout HCT 116 Cell Line compatible with overexpression rescue experiments?
Yes. NHE3 rescue experiments require attention to apical targeting and regulatory complexity:
• Construct design: use a codon-modified SLC9A3 sequence with a C-terminal cytoplasmic tag (FLAG, HA). NHE3 has 12 transmembrane domains and a large cytoplasmic regulatory C-terminus that contains NHERF-binding motifs.
• Regulatory mutant rescue: NHERF-binding-deficient mutations or specific phosphorylation site mutations (S552A, S605A) enable dissection of regulatory inputs.
• Trafficking-deficient rescue: cytoplasmic tail mutations affecting trafficking machinery interactions test apical surface delivery requirements.
• Functional readout: rescue should restore Na+/H+ exchange activity measured by BCECF-based intracellular pH recovery assays.
HCT 116 transduces efficiently with lentivirus; the MSI-high colorectal cancer background should be considered when interpreting epithelial transport studies.
* Research Use Disclaimer: Content is generated from publicly available research data, bioinformatic resources, and computational analyses for research reference only.